Found: 9
Select item for more details and to access through your institution.
How to conduct successful forced degradation studies - Scope and regulatory requirements.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2020, v. 82, n. 1, p. 55
- By:
- Publication type:
- Article
How to conduct successful forced degradation studies - Scope and regulatory requirements.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2019, v. 81, n. 11, p. 1481
- By:
- Publication type:
- Article
How to conduct successful forced degradation studies - Scope and regulatory requirements: Part I.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2019, v. 81, n. 9, p. 1192
- By:
- Publication type:
- Article
Scientific and regulatory aspects of solid phase reactions in forced degradation studies.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2015, v. 77, n. 12, p. 1731
- By:
- Publication type:
- Article
Scientific and regulatory aspects of solid phase reactions in forced degradation studies: Part 1: A practical approach and regulatory considerations of forced degradation studies.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2015, v. 77, n. 10, p. 1484
- By:
- Publication type:
- Article
Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 20, p. 12555, doi. 10.1093/nar/gku1033
- By:
- Publication type:
- Article
Studies on the chemistry of thienoannelated O,N- and S,N-containing heterocycles. 24 [1]. Synthesis of imidazo[1,5- d]thieno[2,3- b][1,4]-thiazine derivatives as potential receptor ligands.
- Published in:
- Journal of Heterocyclic Chemistry, 2002, v. 39, n. 4, p. 645, doi. 10.1002/jhet.5570390407
- By:
- Publication type:
- Article
Cyclooxygenase-1 and Cyclooxygenase-2 Inhibition of Novel 1,2-Disubtituted Imidazoles.
- Published in:
- Archiv der Pharmazie, 2005, v. 338, n. 12, p. 602, doi. 10.1002/ardp.200500178
- By:
- Publication type:
- Article
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 5, p. 393, doi. 10.1007/s10637-008-9183-7
- By:
- Publication type:
- Article